[A NEW MAJOR NEUROLEPTIC AGENT: TRIPERIDOL. 1ST CLINICAL RESULTS OBTAINED WITH A NEW BUTYROPHENONE DERIVATIVE].
D000293:Adolescent; D014150:Antipsychotic Agents; D002090:Butyrophenones; D005853:Geriatrics; D012559:Schizophrenia; D014116:Toxicology; D014149:Tranquilizing Agents; D014272:Trifluperidol
D014150:Antipsychotic Agents; D002090:Butyrophenones; D014149:Tranquilizing Agents; D014272:Trifluperidol
ADOLESCENCE; GERIATRICS; SCHIZOPHRENIA; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRIFLUPERIDOL
UN NOUVEAU NEUROLEPTIQUE MAJEUR: LE TRIP'ERIDOL. PREMIERS R'ESULTATS CLINIQUES AVEC UN NOUVEAU D'ERIV'E DE LA S'ERIE DES BUTYROPH'ENONES.